doi.org/10.1016/j.chembiol.2019.05.005

Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity

..., Peter K. Sorger
102
Cell chemical biology
Volume: 26, Issue: 8, Pages: 1067 - 1080.e8
Published: Jun 6, 2019
Paper Fields
Paper Details
Title
Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity
DOI
doi.org/10.1016/j.chembiol.2019.05.005
Published Date
Jun 6, 2019
Journal
Cell chemical biology
Volume
26
Issue
8
Pages
1067 - 1080.e8
© 2026 Pluto Labs All rights reserved.